The US Federal Trade Commission has agreed with Apple’s view of Qualcomm licensing practices, and a trial over the government’s antitrust case is in its second week in San Jose, California, reported Bloomberg.
The US Patent and Trademark Office has decided to wade into a global licensing battle between Apple and Qualcomm, with billions of dollars at stake.
The Patent Trial and Appeal Board agreed to consider the validity of two Qualcomm patents, according to notices posted on its electronic docket Tuesday, January 15. Apple and ally Intel had claimed the patents didn’t cover new inventions and the board conducted a preliminary analysis to determine if Apple had a “reasonable likelihood” of winning its argument. The Board will hear arguments from both sides and issue a final decision in about a year.
Apple and Qualcomm are locked in a worldwide dispute over licensing fees for use of Qualcomm’s technology. Apple has argued its former supplier unfairly leverages its position as the biggest supplier of chips for smartphones to force payment. Qualcomm has countered that Apple is using its intellectual property without paying for it, and the legal cases are aimed at forcing it to reduce licensing charges.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI